These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34571173)

  • 1. Piperazine squaric acid diamides, a novel class of allosteric P2X7 receptor antagonists.
    Patberg M; Isaak A; Füsser F; Ortiz Zacarías NV; Vinnenberg L; Schulte J; Michetti L; Grey L; van der Horst C; Hundehege P; Koch O; Heitman LH; Budde T; Junker A
    Eur J Med Chem; 2021 Dec; 226():113838. PubMed ID: 34571173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Investigation on Linker Modifications of Cyanoguanidine-Based P2X7 Receptor Antagonists.
    Garrett TR; Gilchrist J; McKenzie ADJ; Larik FA; Danon JJ; Werry EL; Kassiou M
    ChemMedChem; 2024 Sep; 19(17):e202400163. PubMed ID: 38782733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2X7 receptor inhibition by 2-amino-3-aryl-1,4-naphthoquinones.
    de Luna Martins D; Borges AA; E Silva NADA; Faria JV; Hoelz LVB; de Souza HVCM; Bello ML; Boechat N; Ferreira VF; Faria RX
    Bioorg Chem; 2020 Nov; 104():104278. PubMed ID: 33010623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship studies of pyrimidine-2,4-dione derivatives as potent P2X7 receptor antagonists.
    Park JH; Lee GE; Lee SD; Ko H; Kim YC
    Eur J Med Chem; 2015 Dec; 106():180-93. PubMed ID: 26547056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel P2X7R antagonists by using structure-based virtual screening and cell-based assays.
    Zhao Y; Chen X; Lyu S; Ding Z; Wu Y; Gao Y; Du J
    Chem Biol Drug Des; 2021 Jul; 98(1):192-205. PubMed ID: 33993620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a Novel Class of Multitarget-Directed Ligands: Dual P2X7-NMDA Receptor Antagonists.
    Karoutzou O; Kwak SH; Lee SD; Martínez-Falguera D; Sureda FX; Vázquez S; Kim YC; Barniol-Xicota M
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29361735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic 1,4-Naphthoquinones inhibit P2X7 receptors in murine neuroblastoma cells.
    Pislyagin E; Kozlovskiy S; Menchinskaya E; Chingizova E; Likhatskaya G; Gorpenchenko T; Sabutski Y; Polonik S; Aminin D
    Bioorg Med Chem; 2021 Feb; 31():115975. PubMed ID: 33401207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
    Allsopp RC; Dayl S; Schmid R; Evans RJ
    Sci Rep; 2017 Apr; 7(1):725. PubMed ID: 28389651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploratory study of oxatomide derivatives with high P2X
    Yamagiwa N; Komine M; Hanaoka F; Nobuta T; Yoshida K; Ito M; Matsuoka I
    Bioorg Med Chem Lett; 2022 Dec; 77():129035. PubMed ID: 36283612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the Site of Action of Human P2X7 Receptor Antagonists AZ11645373, Brilliant Blue G, KN-62, Calmidazolium, and ZINC58368839 to the Intersubunit Allosteric Pocket.
    Bin Dayel A; Evans RJ; Schmid R
    Mol Pharmacol; 2019 Sep; 96(3):355-363. PubMed ID: 31263019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrotanshinone, a Natural Diterpenoid, Preserves Blood-Retinal Barrier Integrity via P2X7 Receptor.
    Fresta CG; Caruso G; Fidilio A; Platania CBM; Musso N; Caraci F; Drago F; Bucolo C
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,4-Naphthoquinones potently inhibiting P2X7 receptor activity.
    Faria RX; Oliveira FH; Salles JP; Oliveira AS; von Ranke NL; Bello ML; Rodrigues CR; Castro HC; Louvis AR; Martins DL; Ferreira VF
    Eur J Med Chem; 2018 Jan; 143():1361-1372. PubMed ID: 29133043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2X7 receptor antagonism: Implications in diabetic retinopathy.
    Platania CBM; Giurdanella G; Di Paola L; Leggio GM; Drago F; Salomone S; Bucolo C
    Biochem Pharmacol; 2017 Aug; 138():130-139. PubMed ID: 28479300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of bilirubin as novel P2X7R antagonist with anti-tumor activity.
    Zhao Y; Chen X; He C; Gao G; Chen Z; Du J
    Bioorg Med Chem Lett; 2021 Nov; 51():128361. PubMed ID: 34543755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Evaluation of Novel Bioisosteres of an Adamantanyl Benzamide P2X
    Wilkinson SM; Barron ML; O'Brien-Brown J; Janssen B; Stokes L; Werry EL; Chishty M; Skarratt KK; Ong JA; Hibbs DE; Vugts DJ; Fuller S; Windhorst AD; Kassiou M
    ACS Chem Neurosci; 2017 Nov; 8(11):2374-2380. PubMed ID: 28841278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-Hydroxy-2-(1H-1,2,3-triazol-1-yl)-1,4-naphtoquinone derivatives inhibited P2X7 Receptor-Induced dye uptake into murine Macrophages.
    Pacheco PAF; Galvão RMS; Faria AFM; Von Ranke NL; Rangel MS; Ribeiro TM; Bello ML; Rodrigues CR; Ferreira VF; da Rocha DR; Faria RX
    Bioorg Med Chem; 2019 Apr; 27(8):1449-1455. PubMed ID: 30528164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.
    Kwak SH; Shin S; Lee JH; Shim JK; Kim M; Lee SD; Lee A; Bae J; Park JH; Abdelrahman A; Müller CE; Cho SK; Kang SG; Bae MA; Yang JY; Ko H; Goddard WA; Kim YC
    Eur J Med Chem; 2018 May; 151():462-481. PubMed ID: 29649742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escape from adamantane: Scaffold optimization of novel P2X7 antagonists featuring complex polycycles.
    Barniol-Xicota M; Kwak SH; Lee SD; Caseley E; Valverde E; Jiang LH; Kim YC; Vázquez S
    Bioorg Med Chem Lett; 2017 Feb; 27(4):759-763. PubMed ID: 28126517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X₇ receptor.
    Subramanyam C; Duplantier AJ; Dombroski MA; Chang SP; Gabel CA; Whitney-Pickett C; Perregaux DG; Labasi JM; Yoon K; Shepard RM; Fisher M
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5475-9. PubMed ID: 21782426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From lead to clinic: A review of the structural design of P2X7R antagonists.
    Zhang R; Li N; Zhao M; Tang M; Jiang X; Cai X; Ye N; Su K; Peng J; Zhang X; Wu W; Ye H
    Eur J Med Chem; 2023 May; 251():115234. PubMed ID: 36893624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.